Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Sysmex Corporation

Market Cap 839B 5.2B 4.54B 4.2B 3.93B 7.38B 491B 7.42B 49.86B 19.32B 242B 19.54B 19.12B P/E 2026
24.1x
P/E 2027 * 20.5x
Enterprise Value 800B 4.96B 4.32B 4.01B 3.75B 7.03B 468B 7.07B 47.51B 18.41B 230B 18.62B 18.22B EV / Sales 2026
1.68x
EV / Sales 2027 * 1.57x
Free-Float
72.3%
Yield 2026
2.78%
Yield 2027 * 2.74%
1 day+5.89%
1 month+5.89%
3 months+4.93%
6 months-5.14%
Current year-10.38%
1 month 8.85
Extreme 8.85
8.85
Current year 7.97
Extreme 7.97
9.35
1 year 7.97
Extreme 7.97
17.52
3 years 7.97
Extreme 7.97
22.18
5 years 7.97
Extreme 7.97
45.45
10 years 7.97
Extreme 7.97
45.45
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 69 01/06/2020
Director/Board Member 67 01/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
+5.89%-.--% - - 5.2B
-0.10%+0.26%-33.52%-17.14% 154B
+1.54%-1.07%-8.11%-10.79% 102B
-4.45%+3.12%+61.36%+57.49% 56.51B
-1.90%-3.49%-7.43%+47.34% 52.89B
+1.67%-1.55%-14.51%-43.86% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-44.24% 27.96B
+1.35%-0.26%+51.96%-10.42% 23.17B
-1.53%+1.14%-15.21%-5.72% 20.35B
Average +0.29%-1.30%+3.14%-3.42% 56.28B
Weighted average by Cap. -0.21%-1.24%-6.00%-2.77%

Financials

2026 2027 *
Net sales 501B 3.1B 2.71B 2.51B 2.35B 4.4B 293B 4.43B 29.74B 11.53B 144B 11.65B 11.4B 534B 3.31B 2.89B 2.67B 2.5B 4.7B 313B 4.72B 31.73B 12.3B 154B 12.43B 12.17B
Net income 34.35B 213M 186M 172M 161M 302M 20.1B 304M 2.04B 791M 9.89B 800M 782M 40.99B 254M 222M 205M 192M 360M 23.98B 363M 2.43B 944M 11.8B 954M 934M
Net Debt -39.41B -244M -213M -197M -185M -346M -23.06B -349M -2.34B -907M -11.35B -917M -898M 243M 1.51M 1.31M 1.22M 1.14M 2.13M 142M 2.15M 14.43M 5.59M 69.94M 5.65M 5.53M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,533
Date Price Change Volume
17/06/26 - $ - 39
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,364.00JPY
Average target price
1,719.33JPY
Spread / Average Target
+26.05%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!